drugset / Trial / NCT07485595
A Study of the Effectiveness and Safety of JS1-1-01 Tablet in Patients With Moderate to Severe Depression
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The purpose of this study is to evaluate the Effectiveness and Safety of JS1-1-01 Tablet in Patients With Moderate to Severe Depression
Timeline
- Start
- 2026-04-30
- Primary completion
- 2026-12-31
- Completion
- 2026-12-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | JS1-1-01 | Unknown | 75 mg | — |
| Subject | JS1-1-01 | Unknown | 100 mg | — |